This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
News & Press: Position Statements

Joint Statement from ISPAD, ADA, JDRF on Unproven Therapies for Type 1 Diabetes

Thursday, September 13, 2018  
Posted by: ISPAD Secretariat

The International Society for Pediatric Diabetes (ISPAD), the American Diabetes Association (ADA), and JDRF (formerly known as the Juvenile Diabetes Research Foundation) are committed to the support of innovative laboratory research, therapeutic strategies and clinical trials. However, the provision of unproven treatments to patients, particularly (but not exclusively) in a for-profit context, raises major ethical and safety concerns. The vast majority of potential new therapies that show promise in early stage laboratory studies in animal models are found to be unsafe and/or ineffective when tested in randomized, placebo-controlled clinical studies in humans and cannot be supported by published evidence. It is, therefore, our position that unproven treatments that are believed by the medical and research communities to have clinical potential should only be prescribed to patients in the context of carefully monitored clinical trials. The therapeutic value and safety of all treatments and agents must be evaluated rigorously, and human subject (patient) protections must be in place. We do not endorse any drug or other agent, or treatment protocol that has not been evaluated by strict scientific methodology, conforming to FDA and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) best practices, to demonstrate safety and effectiveness, and to validate a change in the standard of care.



Contact Us

ISPAD Executive Office
c/o K.I.T. Group GmbH
Association & Conference Management
Kurfürstendamm 71
10709 Berlin, Germany


Click the link below to join the Society!

Join Today!

Phone: +49 (0)30 24603-210
Fax: +49 (0)30 24603-200
Email: secretariat@ispad.or

Privacy Policy
Terms of Service
Legal Notice    


 © 2020 International Society for Pediatric and Adolescent Diabetes (ISPAD)

Association Management Software Powered by YourMembership  ::  Legal